Basic Information
Basic information for UCA1-245-26aa
Peptide Name UCA1-245-26aa
Genome Position chr19:15835324-15835401[+]
Species Human
Peptide Sequence MENGDKRLWYIKHYSFLGLKTHRHLH
Peptide Length 26
Unique No (UCA1-201-26aa,UCA1-202-26aa,UCA1-203-26aa-2,UCA1-204-26aa,UCA1-205-26aa,UCA1-207-26aa,UCA1-208-26aa,UCA1-209-26aa,UCA1-210-26aa,UCA1-211-26aa,UCA1-212-26aa,UCA1-213-26aa,UCA1-216-26aa,UCA1-218-26aa,UCA1-220-26aa,UCA1-221-26aa,UCA1-222-26aa,UCA1-224-26aa,UCA1-225-26aa,UCA1-227-26aa,UCA1-228-26aa,UCA1-229-26aa,UCA1-230-26aa,UCA1-231-26aa,UCA1-232-26aa,UCA1-233-26aa,UCA1-234-26aa,UCA1-235-26aa,UCA1-237-26aa,UCA1-238-26aa,UCA1-239-26aa,UCA1-240-26aa,UCA1-241-26aa,UCA1-244-26aa)
Grand Average of Hydropathicity -0.9769
Relative Molecular Mass 3731.2
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000214049;UCA1
Transcript ID/Name ENST00000671188;UCA1-245
Transcript Length 1287
Coding Ability 0.4118
DNA Sequence Corresponding to Peptide ATGGAAAATGGGGACAAAAGGCTTTGGTACATAAAACATTATTCCTTCCTTGGCCTAAAAACTCATCGCCACCTACAT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :